University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Voices Of Individuals: Challenges and Experiences Of bvFTD

Active, not recruiting

Conditions: FTD
Frontotemporal Degeneration
Frontotemporal Dementia
Frontotemporal Dementia, Behavioral Variant

Interventions: Other: Telephone Interview

First Posted Date: 2019-08-16

Last Posted Date: 2025-02-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT04060082

Locations: 🇺🇸
Johns Hopkins Medical Institution, Baltimore, Maryland, United States
🇺🇸
National Institutes of Health (NIH), Bethesda, Maryland, United States
🇺🇸
University of Pennsylvania (Penn Frontotemporal Degeneration Center), Philadelphia, Pennsylvania, United States

Move to Improve Physical Activity in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson Disease
Apathy

Interventions: Behavioral: Gameficiation

First Posted Date: 2019-08-09

Last Posted Date: 2024-01-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 84

Registration Number: NCT04051151

Locations: 🇺🇸
University of Pennsylvania's Parkinson's Disease and Movement Disorder Center, Philadelphia, Pennsylvania, United States

Noninvasive Brain Stimulation to Enhance Cognitive Training in Older Adults

Not Applicable

Completed

Conditions: Normal Aging

Interventions: Device: Transcranial Direct Current Stimulation
Behavioral: Computer-based cognitive therapy (CBCT)

First Posted Date: 2019-08-08

Last Posted Date: 2021-02-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT04050046

tDCS to Treat Subacute Aphasia

Not Applicable

Withdrawn

Conditions: Stroke, Acute
Aphasia

Interventions: Device: Transcranial Direct Current Stimulation (tDCS)

First Posted Date: 2019-08-07

Last Posted Date: 2024-08-07

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04048668

Locations: 🇺🇸
Penn Institute for Rehabilitation Medicine, Philadelphia, Pennsylvania, United States

Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS

Phase 2

Active, not recruiting

Conditions: Primary Progressive Aphasia

Interventions: Device: high-definition transcranial direct current stimulation
Behavioral: modified constraint-induced language therapy

First Posted Date: 2019-08-06

Last Posted Date: 2024-10-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 66

Registration Number: NCT04046991

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Magnetic Stimulation to Treat VT Storm

Not Applicable

Completed

Conditions: Ventricular Tachycardia

Interventions: Device: Magstim SuperRapid

First Posted Date: 2019-08-02

Last Posted Date: 2022-11-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 26

Registration Number: NCT04043312

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Transcranial Direct Current Stimulation Investigations of Language Processing in Aphasia

Not Applicable

Completed

Conditions: Aphasia

Interventions: Device: Transcranial Direct Current Stimulation (tDCS)

First Posted Date: 2019-08-01

Last Posted Date: 2019-08-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 25

Registration Number: NCT04041986

Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients

Recruiting

Conditions: GM1 Gangliosidosis

First Posted Date: 2019-08-01

Last Posted Date: 2024-10-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 40

Registration Number: NCT04041102

Locations: 🇺🇸
UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
🇹🇷
Gazi University, Ankara, Turkey

and more 3 locations

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Phase 3

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: Anti Arrhythmics
Procedure: Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation

First Posted Date: 2019-07-30

Last Posted Date: 2024-11-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 25

Registration Number: NCT04037397

Locations: 🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
MetroHealth, Cleveland, Ohio, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States

and more 2 locations

Pitocin or Oral Misoprostol for PROM IOL

Phase 4

Completed

Conditions: PROM

Interventions: Drug: Misoprostol
Drug: Oxytocin

First Posted Date: 2019-07-23

Last Posted Date: 2024-04-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 108

Registration Number: NCT04028765

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy